AI Signal & Stock Analysis · Neutral →
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for JAZZ is Neutral →; the stock is at $244.09 (-0.72% today); neutral (RSI 44); technical trend is down-trend; news sentiment is positive.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Neutral → |
|---|---|
| Price | $244.09 |
| Change today | -0.72% |
| RSI (14) | 43.80 |
| Relative volume | 0.37 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $15.8B |
| Forward P/E | 9.43 |
| 52-week high | -7.8% away |
| 52-week low | +112.2% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Positive |
| Sector | Healthcare-Biotech |
| Next earnings | 8/3/2026 4:30:00 PM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns JAZZ (Jazz Pharmaceuticals plc) a Neutral signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
JAZZ's RSI is neutral (RSI 44). A reading above 70 is typically considered overbought and below 30 oversold.
JAZZ is trading about 8% below its 52-week high and 112% above its 52-week low as of Aug 14 2026, 1:04 PM.
JAZZ's next earnings date is 8/3/2026 4:30:00 PM.
JAZZ is classified under Healthcare-Biotech in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.